These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17517623)

  • 1. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
    Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
    Opattova A; Filipcik P; Cente M; Novak M
    J Alzheimers Dis; 2013; 33(2):339-48. PubMed ID: 22936006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
    Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
    Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
    Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
    J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
    Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
    Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Proteostasis in Neurodegenerative Tauopathies.
    Papanikolopoulou K; Skoulakis EMC
    Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
    Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
    J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 activator Aha1 drives production of pathological tau aggregates.
    Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
    Paquet D; Schmid B; Haass C
    Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules.
    Jinwal UK; Koren J; Borysov SI; Schmid AB; Abisambra JF; Blair LJ; Johnson AG; Jones JR; Shults CL; O'Leary JC; Jin Y; Buchner J; Cox MB; Dickey CA
    J Neurosci; 2010 Jan; 30(2):591-9. PubMed ID: 20071522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain.
    Sahara N; Maeda S; Yoshiike Y; Mizoroki T; Yamashita S; Murayama M; Park JM; Saito Y; Murayama S; Takashima A
    J Neurosci Res; 2007 Nov; 85(14):3098-108. PubMed ID: 17628496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.
    Miyata Y; Koren J; Kiray J; Dickey CA; Gestwicki JE
    Future Med Chem; 2011 Sep; 3(12):1523-37. PubMed ID: 21882945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation.
    Thompson AD; Scaglione KM; Prensner J; Gillies AT; Chinnaiyan A; Paulson HL; Jinwal UK; Dickey CA; Gestwicki JE
    ACS Chem Biol; 2012 Oct; 7(10):1677-86. PubMed ID: 22769591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
    Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
    Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathies and tau oligomers.
    Takashima A
    J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.
    Tortosa E; Santa-Maria I; Moreno F; Lim F; Perez M; Avila J
    J Alzheimers Dis; 2009; 17(2):319-25. PubMed ID: 19363271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1.
    Peak SL; Gracia L; Lora G; Jinwal UK
    Neuroscience; 2021 Jan; 453():312-323. PubMed ID: 33246057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.